This RFP is issued to solicit new research projects to enhance and expand MARCE’s current research portfolio. Applications for basic and applied research specific to NIAID Category A, B, or C pathogens or toxins with specific priorities for the following areas of research:
Category A Diagnostics
Category B Diagnostics (i.e. Ricin, West Nile, Enterics)
Plague
MARCE will provide up to $150,000 direct costs per year for up to a 3-year period. Funding beyond the initial period will be contingent upon competitive renewal of the MARCE cooperative agreement (NIH/NIAID U54-AI57168).
Priority Areas:
Category A Diagnostics.
Category B Diagnostics (e.g., ricin, enterics).
Yersinia pestis (Plague).
Therapeutics for ricin intoxication.
Therapeutics for enteric infections.
Genetic systems to construct mutants of Category A-C agents.
Animal modeling of Category A-C agent infections.
Public Health research projects involving collaborations with state health departments.
For the complete announcement, please access the following link:
New Research Projects RFP